ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,048Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 288

$483K Total Retail Price of All Prescriptions

Rank: 77 out of 288

390 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,382 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 563 539 1 1
FUROSEMIDE 362 342 2 5
LISINOPRIL 351 321 3 4
ATENOLOL 310 297 4 10
AMLODIPINE BESYLATE 283 273 5 6
OMEPRAZOLE 269 248 6 3
HYDROCODONE-ACETAMINOPHEN 261 241 S3 7 7
ATORVASTATIN CALCIUM 255 242 8 14
GABAPENTIN 254 252 9 17
LEVOTHYROXINE SODIUM 249 233 10 2
ALENDRONATE SODIUM 189 172 11 20
SERTRALINE HCL 172 161 12 25
WARFARIN SODIUM 163 154 13 9
METOPROLOL SUCCINATE 161 145 14 15
METFORMIN HCL 151 135 15 12
HYDROCHLOROTHIAZIDE 149 142 16 13
TRIAMTERENE-HCTZ 148 143 17 28
POTASSIUM CHLORIDE 146 129 18 11
METOPROLOL TARTRATE 144 137 19 8
MELOXICAM 136 128 20 44
NAMENDA 135 128 21 39
NIASPAN 118 96 22 103
PREDNISONE 117 113 23 30
TAMSULOSIN HCL 100 100 24 24
PAROXETINE HCL 98 98 25 54
PRAVASTATIN SODIUM 93 88 26 21
SUCRALFATE 78 77 27 155
ALLOPURINOL 73 73 28 23
CRESTOR 71 66 29 26
VERAPAMIL ER 70 70 30 97
CARBIDOPA-LEVODOPA 69 69 31 72
FENOFIBRATE 66 53 32 61
AGGRENOX 64 62 33 136
TERAZOSIN HCL 63 63 34 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 56 35 34
DIOVAN 60 60 36 53
GLIPIZIDE ER 59 57 37 93
CARVEDILOL 59 55 37 27
DILTIAZEM 24HR CD 55 45 39 75
FINASTERIDE 55 51 39 82
NEXIUM 53 53 41 43
TRAMADOL HCL 52 36 42 19
ISOSORBIDE MONONITRATE ER 52 50 42 35
CYMBALTA 50 48 44 67
DETROL LA 50 50 44 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.